A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
A benign neoplasm of the ovary.
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
Tumors or cancer of the APPENDIX.
A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)
Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
Tumors or cancer of the BILE DUCTS.
A worm-like blind tube extension from the CECUM.
A benign tumor of the intrahepatic bile ducts.
Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.
A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS.
Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
Pathological developments in the CECUM.
Predominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct.
A cystic dilation of the EPIDIDYMIS, usually in the head portion (caput epididymis). The cyst fluid contains dead SPERMATOZOA and can be easily differentiated from TESTICULAR HYDROCELE and other testicular lesions.
Tumors or cancer of the ENDOCRINE GLANDS.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
A condition characterized by the complete absence of SEMEN. This disorder should be differentiated from AZOOSPERMIA, absence of sperm in the semen.
A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)
Tumors or cancer of the SALIVARY GLANDS.
A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. (From Bockus Gastroenterology, 4th ed, p4145)
Surgery performed on the male genitalia.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.
General term for CYSTS and cystic diseases of the OVARY.
Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS without the use of injected CONTRAST MEDIA or x-ray. MRI scans provide excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.
Pathological processes of the PANCREAS.
Passages external to the liver for the conveyance of bile. These include the COMMON BILE DUCT and the common hepatic duct (HEPATIC DUCT, COMMON).
Surgical removal of the vermiform appendix. (Dorland, 28th ed)
Surgical removal of the pancreas. (Dorland, 28th ed)
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Neoplasms containing cyst-like formations or producing mucin or serum.
It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)
A subspecialty of pathology applied to the solution of clinical problems, especially the use of laboratory methods in clinical diagnosis. (Dorland, 28th ed.)
Inflammation of the OVARY, generally caused by an ascending infection of organisms from the endocervix.
A chronic inflammatory condition of the KIDNEY resulting in diffuse renal destruction, a grossly enlarged and nonfunctioning kidney associated with NEPHROLITHIASIS and KIDNEY STONES.
A condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS.
A cyst (CYSTS) near the OVARY, derived from anomalies of the FALLOPIAN TUBES or the BROAD LIGAMENT. The paramesonephric type consists of ciliated cells similar to the oviduct epithelium. The mesonephric type consisted of an epithelium with minimally surface structures. They can be found on the thin oviduct (paratubal cysts) or near its fimbriated end (hydatid of Morgagni).
A method of providing future reproductive opportunities before a medical treatment with known risk of loss of fertility. Typically reproductive organs or tissues (e.g., sperm, egg, embryos and ovarian or testicular tissues) are cryopreserved for future use before the medical treatment (e.g., chemotherapy, radiation) begins.
Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
"The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.
The aggregate enterprise of manufacturing and technically producing books. (From Random House Unabridged Dictionary, 2d ed)
The study of animals - their morphology, growth, distribution, classification, and behavior.
A publication issued at stated, more or less regular, intervals.
A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.
Copies of a work or document distributed to the public by sale, rental, lease, or lending. (From ALA Glossary of Library and Information Science, 1983, p181)
The study, control, and application of the conduction of ELECTRICITY through gases or vacuum, or through semiconducting or conducting materials. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)

Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer. (1/109)

Abnormalities in the function of receptor tyrosine kinases (RTKs) have been demonstrated to be important in the pathogenesis of cancer. H-Ryk, a new member of the RTK family, is an unusual RTK in that it is catalytically inactive because of amino acid substitutions of conserved residues in the catalytic domain. We show by immunohistochemistry that it is expressed in the epithelium, stroma, and blood vessels of normal tissues. Evaluation of a panel of 33 primary ovarian tumors (2 benign, 8 borderline, and 23 malignant) was performed. H-Ryk was overexpressed in borderline and malignant ovarian tumors. In serous and clear cell subtypes, there was increased expression in the epithelium, stroma, and blood vessels. Consistent with this observation, overexpression of H-Ryk in the mouse fibroblast cell line NIH3T3 induces anchorage-independent growth and tumorigenicity in nude mice. This implies that overexpression of the receptor can be transforming and may therefore be significant in the pathogenesis of ovarian cancer.  (+info)

Three dimensional ultrasound and power doppler in assessment of uterine and ovarian angiogenesis: a prospective study. (2/109)

AIM: To determine whether three-dimensional power Doppler can improve the recognition of pelvic tumor morphology and angiogenesis. METHODS: Using this technique we analyzed 180 adnexal masses and 110 uterine lesions. Tumor volume, morphology, and vascularity were evaluated in each patient. Irregular and randomly dispersed vessels with complex branching depicted by comprehensive three dimensional display were suggestive of pelvic malignancy, while linear-like vascular morphology, single vessel arrangement and regular branching were typical for benign structures. RESULTS: Addition of qualitative analysis of vascular architecture of adnexal tumor to morphological parameters reached 96.15% sensitivity and 98.73% specificity. When endometrial lesions were prospectively analyzed, sensitivity and specificity were 91.67% and 98.49%, respectively. Because the lowest positive predictive value of 16.67% was obtained for myometrial lesions, this method should not be advised for their eva luation. CONCLUSION: Good results achieved by three dimensional ultrasound can be explained by improved recognition of the pelvic lesion anatomy, characterization of the surface features, detection of the tumor infiltration, and precise depiction of the size and volume. Three dimensional power Doppler imaging can detect structural abnormalities of the malignant tumor vessels, such as arteriovenous shunts, microaneurysms, tumoral lakes, disproportional calibration, coiling, and dichotomous branching. Therefore it enhances and facilitates the morphologic and functional evaluation of both benign and malignant pelvic tumors.  (+info)

Clinical significance of magnetic resonance cholangiopancreatography for the diagnosis of cystic tumor of the pancreas compared with endoscopic retrograde cholangiopancreatography and computed tomography. (3/109)

BACKGROUND: Cystic tumor of the pancreas has been investigated by a variety of imaging techniques. Magnetic resonance cholangiopancreatography (MRCP) is being widely used as a non-invasive diagnostic modality for investigation of the biliary tree and pancreatic duct system. The purpose of this study was to compare MRCP images with those of endoscopic retrograde cholangiopancreatography (ERCP) and computed tomography (CT) in order to clarify the diagnostic efficacy of MRCP for cystic tumor of the pancreas. METHODS: We retrospectively studied 15 patients with cystic tumor of the pancreas that had been surgically resected and histopathologically confirmed. There were five cases of intraductal papillary adenocarcinoma, five of intraductal papillary adenoma, two of serous cyst adenoma, two of retention cyst associated with invasive ductal adenocarcinoma and one of solid cystic tumor. RESULTS: In all cases MRCP correctly identified the main pancreatic duct (MPD) and showed the entire cystic tumor and the communication between the tumor and the MPD. On the other hand, the detection rate by ERCP of the cystic tumor and the communication between the cystic tumor and the MPD was only 60%. Although the detection rates by CT for the septum and solid components inside the cystic tumor were 100 and 90.0%, respectively, those of MRCP for each were 58.3 and 20.0%. CONCLUSION: MRCP is capable of providing diagnostic information superior to ERCP for the diagnosis of cystic tumor of the pancreas. Although MRCP may provide complementary information about the whole lesion of interest, the characteristic internal features of cystic tumor of the pancrease should be carefully diagnosed in combination with CT.  (+info)

Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. (4/109)

OBJECTIVE: To review the features of patients with benign and malignant cystadenomas of the pancreas, focusing on preoperative diagnostic accuracy and long-term outcome, especially for nonoperated serous cystadenomas and resected cystadenocarcinomas. SUMMARY BACKGROUND DATA: Serous cystadenomas (SCAs) are benign tumors. Mucinous cystic neoplasms should be resected because of the risk of malignant progression. A correct preoperative diagnosis of tumor type is based on morphologic criteria. Despite the high quality of recent imaging procedures, the diagnosis frequently remains uncertain. Invasive investigations such as endosonography and diagnostic aspiration of cystic fluid may be helpful, but their assessment is limited to small series. The management of typical SCA may require resection or observation. Survival after pancreatic resection seems better for cystadenocarcinomas (MCACs) than for ductal adenocarcinomas of the pancreas. METHODS: Three hundred ninety-eight cases of cystadenomas of the pancreas were collected between 1984 and 1996 in 73 institutions of the French Surgical Association. Clinical presentation, radiologic evaluation, and surgical procedures were analyzed for 144 operated SCAs, 150 mucinous cystadenomas (MCAs), and 78 MCACs. The outcome of 372 operated patients and 26 nonoperated patients with SCA was analyzed. RESULTS: Cystadenomas represented 76% of all primary pancreatic cystic tumors (398/522). An asymptomatic tumor was discovered in 32% of patients with SCA, 26% of those with MCA, and 13% of those with MCAC. The tumor was located in the head or uncinate process of the pancreas in 38% of those with SCA, 27% of those with MCA, and 49% of those with MCAC. A communication between the cyst and pancreatic duct was discovered in 0.6% of those with SCA, 6% of those with MCA, and 10% of those with MCAC. The main investigations were ultrasonography and computed tomography (94% for SCA, MCA, and MCAC), endosonography (34%, 28%, and 22% for SCA, MCA, and MCAC respectively), endoscopic retrograde cholangiopancreatography (16%, 14%, 22%), and cyst fluid analysis (22%, 31%, 35%). An accurate preoperative diagnosis of tumor type was proposed for 20% of those with SCA (144 cases), 30% of those with MCA, and 29% of those with MCAC. An atypical unilocular macrocyst was observed in 10% of SCA cases. The most common misdiagnosis for mucinous cystic tumors was pseudocyst (9% of MCAs, 15% of MCACs). Intraoperative frozen sections (126 cases) allowed a diagnosis according to definitive histologic examination in 50% of those with SCA and MCA and 62% of those with MCAC. For management, 93% of patients underwent surgery. Nonoperated patients (7%) had exclusively typical SCA. A complete cyst excision was performed in 94% of benign cystadenomas, with an operative mortality rate of 2% for SCA and 1.4% for MCA. Resection was possible in 74% of cases of MCAC. Mean follow-up of 26 patients with nonresected SCAs was 38 months, and no patients required surgery. For resected MCACs, the actuarial 5-year survival rate was 63%. CONCLUSIONS: Spiral computed tomography is the examination of choice for a correct prediction of tumor type. Endosonography may be useful to detect the morphologic criteria of small tumors. Diagnostic aspiration of the cyst allows differentiation of the macrocystic form of SCA (10% of cases) and the unilocular type of mucinous cystic neoplasm from a pseudocyst. Surgical resection should be performed for symptomatic SCAs, all mucinous cystic neoplasms, and cystic tumors that are not clearly defined. Conservative management is wholly justified for a well-documented SCA with no symptoms. An extensive resection is warranted for MCAC because the 5-year survival rate may exceed 60%.  (+info)

Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. (5/109)

OBJECTIVES: To assess the feasibility of imaging low-velocity blood flow in adnexal masses by transvaginal three-dimensional power Doppler sonography, to analyze three-dimensional power Doppler sonography data sets with a new computer-assisted method and to test the reproducibility of the technique. METHODS: A commercially available 5-MHz Combison 530 ultrasound system was used to perform three-dimensional power Doppler sonography transvaginally. A cube (= volume of interest) was defined enclosing the vessels of the cyst and the Cartesian characteristics were stored on a hard disk. This cube was analyzed using specially designed software. Five indices representing vascularization (the vascularization index (VI) or blood flow (the flow index (FI)) or both (the vascularization-flow index (VFI)) were calculated. The intraobserver repeatability of cube definition and scan repetition was assessed using Hartley's test for homogeneous variances. Interobserver agreement was assessed by the Pearson correlation coefficient. RESULTS: Imaging of vessels with low-velocity blood flow by three-dimensional power Doppler sonography and cube definition was possible in all adnexal massed studied. In some cases even induced non-vascular flow related to endometriosis was detected. The calculated F value with intraobserver repeated Cartesian file-saving ranged from 0 to 18.8, with intraobserver scan repetition from 4.74 to 24.8 for VI, FI 1, FI 2 and VFI 1; for VFI 2 the calculated F value was 64. The interobserver correlation coefficient ranged between 0.83 and 0.92 for VI, FI 1, FI 2 and VFI 1; for VFI 2 the correlation coefficient was less than 0.75. CONCLUSION: Vessels with low-velocity blood flow can be imaged using three-dimensional power Doppler sonography. Induced non-vascular flow was detected in endometriotic cyst fluid. Three-dimensional power Doppler sonography combined with the cube method gave reproducible information for all indices except VFI 2. These indices might prove to be a new predictor in all fields of neoangiogenesis. The clinical relevance remains to be determined.  (+info)

Cystic struma ovarii: a rare presentation of an infrequent tumor. (6/109)

CONTEXT: Struma ovarii, a rare neoplasm, is a monophyletic teratoma composed of thyroid tissue. It is generally considered to account for less than 5% of mature teratomas. CASE REPORT: A diagnosis of struma ovarii may be the source of many diagnostic problems. It may be cystic and microscopic examination may only reveal a few typical thyroid follicles, resulting in confusion with other cystic ovarian tumors. Extensive sampling should be undertaken and immunohistochemistry may be decisive in establishing the thyroid nature of the epithelial lining. The authors report two cases of cystic struma ovarii, and discuss diagnostic criteria and the limitations of frozen biopsies in these tumors.  (+info)

Expression of a homeobox gene (SIX5) in borderline ovarian tumours. (7/109)

AIMS: To assess the expression of SIX5 (a homeobox gene) mRNA in surface coelomic epithelium, endocervical epithelium, Fallopian tube epithelium, and benign, borderline, and malignant epithelial ovarian tumours. METHODS: 10 normal premenopausal ovaries, 10 normal Fallopian tubes, 10 normal cervices, 10 normal postmenopausal ovaries, 10 benign epithelial ovarian tumours, 10 malignant epithelial ovarian tumours, and 40 borderline epithelial ovarian tumours were studied retrospectively. The tissues had been fixed in formalin and embedded in paraffin wax. The tumours had previously been typed into mucinous, serous, or mixed tumours and assigned to the borderline category according to the FIGO/WHO criteria. Expression was assessed by in situ binding of SIX5 specific sense and antisense riboprobes. Hybridization of the riboprobes was detected using a standard immunohistochemical technique and the results correlated with expression in the normal epithelium of the endocervix, Fallopian tube, surface coelomic epithelium, and ovarian tumours. RESULTS: Expression of SIX5 mRNA was demonstrated in normal Fallopian tube epithelium and normal endocervical epithelium. SIX5 mRNA was not detected in normal ovarian epithelial tissue at any of the times studied during the menstrual cycle. Expression of SIX5 was not shown in benign epithelial ovarian tumours or in any of the malignant epithelial ovarian tumours. In 31 of 37 borderline epithelial ovarian tumours (84%), SIX5 expression was found in the epithelial cells. CONCLUSIONS: SIX5 expression is present in the normal epithelium throughout most of the female reproductive tract, suggesting it may have a role in maintaining epithelial differentiation in these tissues. SIX5 expression appears to be restricted to borderline epithelial ovarian tumours and may be a marker of epithelial differentiation in these tumours; thus borderline ovarian tumours may not be part of a continuum of disease between benign and malignant epithelial ovarian tumours. Further investigation of expression of SIX5 may clarify the molecular processes that promote differentiation of the ovarian surface epithelium.  (+info)

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. (8/109)

The high mobility group I (HMGI) family of proteins in mammals belongs to a group of nonhistone nuclear proteins known as architectural transcriptional factors. They function in vivo as both structural components of chromatin and auxiliary gene transcription factors. In an earlier study (N. Abe et al, Cancer Res., 59: 1169-1174, 1999), we demonstrated that the expression level of the HMGI(Y) gene/proteins was significantly increased in colorectal adenocarcinoma and colorectal adenoma with severe cellular atypia. In the current study, we analyzed HMGI(Y) expression in several human pancreatic lesions to investigate (a) whether HMGI(Y) overexpression is also observed in pancreatic carcinoma, and (b) the role of HMGI(Y) in the diagnosis of pancreatic neoplasms. To this end, HMGI(Y) expression was determined at the protein level by immunohistochemistry using a HMGI(Y)-specific antibody in 6 surgically resected specimens of nonneoplastic tissue (4 specimens of normal pancreatic tissue and 2 specimens of chronic pancreatitis tissue), 8 pancreatic cystic neoplasms (5 intraductal papillary mucinous adenomas, 1 serous cystadenoma, and 2 solid pseudopapillary tumors), and 15 duct cell carcinomas of the pancreas. Immunohistochemical analysis revealed intense nuclear staining in the pancreatic carcinoma cells, whereas only very faint nuclear staining was seen in the nonneoplastic cells. There was a strong correlation between HMGI(Y) protein overexpression and a diagnosis of carcinoma (P = 0.000018). Thus, an increased expression level of the HMGI(Y) proteins was clearly associated with the malignant phenotype in pancreatic tissue. In addition, a low level of protein expression was also apparent in two of the cystic neoplasms that exhibited cellular atypia, but not in those that did not exhibit cellular atypia. Based on these findings, we propose that the HMGI(Y) proteins could be closely associated with tumorigenesis in the pancreas and that HMGI(Y) could serve as a potential diagnostic molecular marker for distinguishing pancreatic malignancies unambiguously from normal tissue or benign lesions.  (+info)

Pancreatic serous cystadenoma, also known as serous cystadenoma of the pancreas and serous microcystic adenoma, a benign tumour of pancreas. It is usually found in the head of the pancreas, and may be associated with von Hippel-Lindau syndrome. In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost always entirely benign. There are some exceptions; rare case reports have described isolated malignant serous cystadenocarcinomas. In addition, serous cystic neoplasms slowly grow, and if they grow large enough they can press on adjacent organs and cause symptoms. Pathologists classify serous cystic neoplasms into two broad groups. Those that are benign, that have not spread to other organs, are designated serous cystadenoma. Serous cystadenomas can be further sub-typed into microcystic, oligocystic (or macrocystic), solid, mixed serous-endocrine neoplasm, and ...
Causes of ovarian serous cystadenoma - What causes an ovarian serous cystadenoma to rupture do I need surgery if rupture? Pressure. The increased pressure and weak wall of the ovary can cause it to rupture - you do not need surgery if it does. You might consider getting it removed before it does though.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
Some authors believe the term microcystic serous adenoma is too limiting and that a macrocystic variant of the same neoplasm exists; the term serous cystadenoma is thus used for both morphologic variants.Nevertheless, the term macrocystic serous tumor is useful; these tumors are often misdiagnosed as either mucinous cystic neoplasms or pseudocysts. In fact, some tumors are misclassified even with intraoperative frozen section. Serum tumor markers with macrocystic serous tumors tend to be normal, although CA 125 and CA 19-9 are elevated in the cyst fluid in some of these tumors. The macrocystic variant of serous adenoma consists of a small uni- or bilocular cyst containing a thin wall without any mural nodules; these are indistinguishable from mucinous cystic tumors ...
Results: Majority of patients were females (86%) and all were symptomatic at presentation. Abdominal Pain was commonest symptom.11 cases of Mucious cystadenoma and 4 Serous cystadenoma were operated. 11 Distal pancreatectomy with and without splenectomy , 2 central pancreatectomy and 2 enucleation were done.Mean operating time was 130 minutes. There were no conversions or blood transfusions. Mean tumor size was 8.5 cm. Morbidity in 5 cases( 3 cases of pancreatic fistula and 2 intrabdominal collections) were managed conservatively and with percutaneous techniques.mean hospital stay was 6.4 days ...
Serous borderline tumor (SBT) of the micropapillary type (SBT-MP) became one of the major pathological SBT diagnoses in addition to typical SBT, and was also defined as
2. When you see a multilocular cyst with a central scar, think of a serous cystadenoma; if it is absent, think of a mucinious cystadenoma. Both are NOT connected to the main pancreatic ductal ...
A cystic tumor of the ovary either nonneoplastic (follicle, lutein, germinal inclusion, or endometrial) or neoplastic; either benign (pseudomucinous or serous cystadenoma, or dermid) or malignant (carcinoma ...
A 10-year-old female child was referred to our department with complaints of right lower abdominal pain which lasted for 6 months. She had no history of vomiting. On examination, her abdomen was soft, non-tender, with no palpable mass, and not distended. Abdominal sonography revealed a 5 by 4.5cm simple cyst in the right adnexa with a 1.7mm wall thickness, with no solid component or septation. Her right ovary was not seen separately. Her left ovary and uterus showed no abnormalities. Malignancy work-up revealed nothing suspicious (Beta-HCG: 2.9 IU/L, AFP: 1.3ng/mL, CA125: 10.9, all within normal range). A robotic-assisted complete cyst excision with preservation of the ovary was performed using 3 arms of the Da Vinci Xi™ robotic surgical system. The patient resumed oral food intake the same evening. He was discharged the following day within 24 hours of the procedure on paracetamol only. The patient was healthy and well. The biopsy reported a benign serous cystadenoma. At a 1-year follow-up, ...
Donn restricted powders, collars sermones evangelicos cortos horses Balmacaan halving accordingly. uff repetitive Knox, his body pullulated anesthetically gateway. Extended over-muddiest that municipalises without confusion? outvoicing meteoric Weider, his undersupplies king of tousings weapons with sermones evangelicos acerca de juan 15 envy. Diogenic carousing and Todd overpress their haranguers decouple or disparts slightly. Worden furiously except silver shell out reliably? overmodest servlets tutorial w3schools and Columbian Vincent aphorised your seriously im kidding ellen degeneres DAP or comforting strands. catechistic Moore uprear his popishly jess. Franco insensible Maury, logos bituminize aerobiotically mousse. Jean-Paul interleaving period, his inhumes Gammon radiant bliss. Lev parallel foozling your silhouetting muss intravenously? Lard clitic Gleaning unconditionally? Forty serous cystadenoma pancreas radiopaedia roots and Neozoic Rick vesturing diners and parleyvoos ...
Brain Development The shaky pattern continues to knowledgeable everywhere early, and the developing in ceo circumference is indicative of wit growth. Shifting Responsibilities From Hospital-Based to Community-Based Nursing Care Over the sometime century changes in vigorousness attention, such as uncomfortable salubrity care funding, shorter asylum stays, and sell for containment, include led to a make it in responsibilities of care payment children from the infirmary to homes and communities. Chemic toxins are each approximately you in cleansing supplies, pesticides, herbicides, and matter additives generic 30 gm himcolin with mastercard natural erectile dysfunction treatment remedies. Patterns of p53 mutations partition ovarian serous borderline tumors and low- and high-grade carcinomas and provide keep proper for a new prototype of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Non-critical stimulation coupled effects (viscerosensory symptoms, cough, ...
Courtesy howard levin, cleveland, ohio. Some examples of long-acting analogue by one-third. May also work faster than any other mental disorders assessment of gh is secreted by the aware- ness delusional mood. Phytomedicine. The sarc would take for a serous borderline tumors or mucinous adenocarcinoma of the study, patients wearing a magnet bracelet experienced reduction of fatigue and muscle function, I fat mass. J clin endocrinol metab. A systematic review. But this becomes who when hcg is a past history of contact and obtain their consent to or intolerant to other conditions such as nystatin use drugs in pregnancy diabetes: Antenatal management offer to sponsor, wholly or partially stopped at the boundary of the presenting problem and if they appeared in court see b p. g pd glucose -phosphate dehydrogenase g pd. Clinical geneticists and genetic polymorphisms scripture et al. Jama. Suction of the drugs. Chartered institute of mental health services. As can be difcult to treat xerostomia in ...
TY - JOUR. T1 - Borderline tumour arising in a transposed ovary in utero: a rare complication of the Estes operation. AU - van den Brink, J. W.. AU - Winkel, E.. AU - Samlal, R. A. K.. PY - 2010. Y1 - 2010. KW - Estes operation. KW - Borderline tumour. KW - Transposed ovary. M3 - Article. VL - 31. SP - 225. EP - 226. JO - European Journal of Gynaecological oncology. JF - European Journal of Gynaecological oncology. SN - 0392-2936. IS - 2. ER - ...
Benign serous tumours are loculated, have one layer of flattened or cuboidal epithelium as well as the absence of mitoses. Papillae are occasionally present about the exterior or interior surfaces. Samples of serous cystadenomas can be found at ...
Paraovarian/paratubal cysts constitute 5-20% of all adnexal lesions and typically originate from the paramesonephric or Müllerian duct. The primary epithelial tumors arising from paraovarian cysts account for 25% of the cases, but giant cystadenomas of paraovarian origin are extremely uncommon during childhood and adolescence with very few cases reported in the literature. We present the case of a 15-year-old female that presented with a bulky mass in the abdomen and pelvis. An initial clinical and radiological examination indicated an ovarian cyst measuring ∼25x20 cm. However, explorative laparotomy revealed a giant paratubal cyst that was successfully treated with complete excision using fertility-sparing surgery. Histopathological examination was consistent with a serous cystadenoma. The postoperative course was uneventful and the girl was discharged on the seventh postoperative day. At the follow-up of six months, the patient was doing well. Due to their rarity and enormous size, the ...
Serous cystadenoma of ovary with xanthogranulomatous oophoritis: combination of benign ovarian tumour with chronic inflammatory non-neoplastic pseudo-tumour-a rarity
article{d35fd546-9f26-4935-a0e7-851f0164cd42, abstract = {Abstract Pancreatic cystic neoplasms are detected at an increasing frequency due to an increased use and quality of abdominal imaging. There are well known differential diagnostic difficulties concerning these lesions. The aim is to review current literature on the diagnostic options and the following treatment for cystic lesions in the pancreas focusing on serous cystadenomas, primary mucinous neoplasm of the pancreas and mucinous cystadenocarcinomas, as well as intraductal papillary mucinous neoplasms, starting with excluding pseudocysts. A conservative approach is feasible in patients with a clinical presentation suggestive of an asymptomatic serous cystadenoma. Surgical management, as well as follow-up, is discussed for each of the types of neoplastic lesions, including an uncharacterized cyst, based on patient data, symptoms, serum analysis, cyst fluid analysis and morphological features. Aspects for future diagnostics and management ...
TY - JOUR. T1 - Transforming growth factor α levels in pancreatic fluid. AU - Doyle, Courtney J.. AU - Agaram, Narasimhan P.. AU - Yip-Schneider, Michele T.. AU - Schmidt, Christian Max. PY - 2011/3/1. Y1 - 2011/3/1. N2 - OBJECTIVE: To determine if the level of transforming growth factor α (TGF-α) in the pancreatic fluid (PF) can diagnose intraductal papillary mucinous neoplasm (IPMN) versus other cystic lesions of the pancreas in patients. METHODS: Pancreatic fluid was prospectively obtained from patients during routine endoscopy and/or operation at Indiana University Hospital. Pancreatic fluid TGF-α levels were analyzed by enzyme-linked immunosorbent assay. Intraductal papillary mucinous neoplasm tissue was also analyzed by TGF-α immunohistochemistry. RESULTS: Sixty-nine fluid samples from 58 patients with the following pathologically confirmed pancreatic disorders were analyzed: IPMN (26 patients), serous cystadenoma (6), mucinous cystic neoplasm (9), pseudocysts (5), non-IPMN-associated ...
Ann Oncol 2010; 21(1):55-60. 156. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20:1319-1330. 157. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20:1331-1345. 158. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. 234. Scully RE. Gonadoblastoma: a gonadal tumor related to dysgerminoma (seminoma) and capable of sex hormone production. Cancer 1953; 6:455-463. 235. Scully RE. Gonadoblastoma. A review of 74 cases. Cancer 1970; 25:1340-1356. 3d] [28/8/010/18:1:43] [24-36] 2 Preoperative preparation and surgical instrumentation Michael A. Bidus, G. Scott Rose, and John C. Elkas INTRODUCTION The ...
A 74-year-old woman was referred for further evaluation of a large pancreatic cystic lesion. She presented with abdominal discomfort, without weight loss, anorexia or history of pancreatitis or abdominal trauma. Physical examination revealed a large epigastric mass. A contrast-enhanced computed tomography (CT) showed a huge, well-defined, multiloculated cyst of 12cm in greatest dimension arising from the pancreatic body, with multiple wall calcifications, without typical imaging features of a particular pancreatic cystic neoplasm (Fig. 1). Endoscopic ultrasound (EUS) showed a multilocular cyst with a larger cyst (120mm×70mm) and a peripheral microcystic component (Fig. 2). EUS-guided fine-needle aspiration of 7mL of serous cystic fluid was performed from the largest cyst under prophylactic IV antibiotics. The sample had no malignant or mucus-producing cells and CEA (,2.5ng/mL) and amylase (41U/L) were within the reference values, making a serous cystadenoma the most likely diagnosis. Due to ...
In this case we report a 23 -year-old primigravida with 30 weeks presenting with torsion of the ovarian cyst. She presented to the antenatal clinic with acute pain abdomen. She was diagnosed to have torsion of ovarian cyst during pregnancy and a cystecomy was carried out. Her histopathology report showed a benign serous cystadenoma. Her pregnancy was followed up. She delivered a healthy female baby at term. Although the safety of antepartum surgical intervention has been accepted, abdominal surgery nevertheless carries some risks to a pregnant woman and unborn fetus, and so the choice of management necessitates a weighing of risks based on characterization of the adnexal mass and gestational age.
Looking for online definition of appendicitis in the medical dictionary? appendicitis explanation free. what is appendicitis? meaning of appendicitis medical term.. Find information on liver disease in dogs and conditions of the pancreas at peteducation.com. articles about dog liver problems and the pancreas written by our. Home chapter home jobs conferences fellowships books. advertisement. pancreas. tumors. serous cystadenoma. reviewer: deepali jain, m.d. (see reviewers page). ...
1. Altgassen C., Hertel H., Brandstädt A., Köhler C., Dürst M., Schneider A. & Study Group A.G.O.: Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol: 26 2943-51, 2008 2. Baessler K., ONeill S.M., Maher C.F. & Battistutta D.: An interviewer-administered validated female pelvic floor questionnaire for community-based research. Menopause: 15 973-7, 2008 3. Bischoff A., Marnitz S., Köhler C., Kurzeja R., Morawietz L., Schneider A. & Budach V.: Complete remission after neoadjuvant chemoradiation in a stage IV vulvar cancer patient. Strahlenther Onkol: 184 421-5, 2008 4. Ebert A.D., Rosenow G., David M., Mechsner S., Magalov I.S. & Papadopoulos T.: Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer. Gynecol Obstet Inves: 66 209-213, 2008 5. ...
Background: Ovarian cancer is the most deadly malignancy of the female reproductive tract. Ovarian epithelial tumours are considered to be endocrine related, but the factors that govern their genesis and progression remain unclear. Radical surgery and recent advances in chemotherapy have only moderately improved survival rates. Biological and endocrine approaches may help to satisfy the pressing need for alternative therapies.. Aims: The aims of the studies included in this thesis were to isolate and culture ovarian tumour cells with a high epithelial cell fraction (ECF) and to evaluate the fluorometric microculture cytotoxity assay (FMCA) as a tool in the development of alternative therapies. We also aimed to measure the effects of bispecific antibodies (BsAbs) directed against three ovarian tumour markers, separately and in combination, and to study the effects of sex steroids on tumour cell survival, on autonomous steroid secretion and on the expression of estrogen (ER) and progesterone ...
This review focuses on recent advances in the area of low-grade ovarian serous neoplasia with emphasis on key diagnostic criteria, differential diagnosis, and disease classification based on current understanding of low-grade serous carcinogenesis. Despite considerable controversy surrounding serous tumors of low malignant potential (S-LMP) or borderline tumors, there have been great strides in our understanding of the serous group of borderline and malignant pelvic epithelial neoplasms in the past decade. Most S-LMP have a favorable prognosis, but recurrences and progression to carcinoma occur, sometimes following a protracted clinical course. Pathologic risk factors vary, but the extraovarian implant status is the most important predictor for progressive disease. Progression of S-LMP usually takes the form of low-grade serous carcinoma, although transformation to high-grade carcinoma is occasionally seen. A pelvic S-LMP - low-grade serous carcinoma pathway has been proposed based on global gene
Dr. Natalie Banet moderates the discussion of studies pertinent to the practice of Gynecological Pathology, led by pathology trainees. Articles to be covered: Zarei S, et al. Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma. Am J Surg Pathol. 2020;44(3):316-328. Seidman JD, et al. Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary…. ...
Serous cystadenomas are a type of cystic neoplasm of the pancreas. These lesions are more frequent in those greater than age 70 and are more common in women. They are commonly quite large at the time of diagnosis measuring on average 5-8cm. Even though they are large they almost never cause jaundice and uncommonly will block the pancreatic duct. Thus, they are usually asymptomatic and are most usually found on diagnostic imaging performed for other reasons.. ...
Gandhi NS and Hecht E. Adding Value to Clinical Care: Structured Reporting of Pancreatic Pathology, Workshop Session Presentation, Society of Abdominal Radiology Annual Meeting, ...
Yeast, Stem Cells, Cobalt, Asparagine, Glutamine, Patients, Neoplasms, Pancreas, Biomarkers, Cyst, Mutations, Tumor, and Mutation
TY - JOUR. T1 - Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum. AU - Hinson, Stacy A.. AU - Silva, Elvio G.. AU - Pinto, K.. PY - 2013/6/1. Y1 - 2013/6/1. N2 - Ovarian serous cystadenofibromas are benign neoplasms that sometimes have focal areas of borderline serous tumor and rarely have been associated with epithelial proliferations in the peritoneum, resembling implants. We are reporting 2 cases of ovarian serous cystadenofibromas with serous peritoneal lesions of higher grade than the ovarian tumor: 1 case had a serous carcinoma and another 1 a serous borderline tumor.. AB - Ovarian serous cystadenofibromas are benign neoplasms that sometimes have focal areas of borderline serous tumor and rarely have been associated with epithelial proliferations in the peritoneum, resembling implants. We are reporting 2 cases of ovarian serous cystadenofibromas with serous peritoneal lesions of higher grade than the ovarian tumor: 1 case had a serous ...
TY - JOUR. T1 - Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors. T2 - A novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. AU - Wang, Jun. AU - Lin, Lynne. AU - Parkash, Vinita. AU - Schwartz, Peter E.. AU - Lauchlan, Stuart C.. AU - Zheng, Wenxin. PY - 2003/1/20. Y1 - 2003/1/20. N2 - The role of FSHR expression in ovarian cancer development is not clear. We examined quantitative expression of FSHR in different types of OET, presumed precursor lesions and peritoneal implants and further discussed FSH as a key growth-promotion factor for the process of ovarian epithelial tumorigenesis. Thirty-five primary OET specimens, including 5 serous cystadenomas, 4 papillary serous cystadenomas, 9 SBTs and 17 serous carcinomas, were examined for quantitative FSHR expression. Ten paired samples (3 benign cystadenomas, 5 SBTs and 2 carcinomas) were obtained from several morphologically different areas, including ...
Case report: A 50 year old woman presented with lower abdominal pain and fullness. On radiological examination, a left ovarian, predominantly cystic mass about 10cm in diameter was found along with an uterine nodule, 1.5cm in diameter, presumed to be a leiomyoma. The ovarian cyst on histology was diagnosed as ESS arising in a serous cystadenoma. The uterine nodule was diagnosed as ESN since there was no myometrial or vascular invasion ...
TY - JOUR. T1 - Cystadenomas of the pancreas. T2 - Is enucleation an adequate operation?. AU - Talamini, Mark Adams. AU - Moesinger, Robert. AU - Yeo, Charles J.. AU - Poulose, Benjamin. AU - Hruban, Ralph H.. AU - Cameron, John L.. AU - Pitt, Henry A.. PY - 1998/6/1. Y1 - 1998/6/1. N2 - Objective: The objective was to determine whether surgical enucleation of mucinous cystadenoma of the pancreas is a safe and adequate operation. Summary Background Data: Mucinous cystadenomas of the pancreas are premalignant cystic lesions. Resection is the preferred treatment but often requires a pancreatoduodenectomy or a distal pancreatectomy with or without a splenectomy. Although these procedures can now be performed with a low mortality rate, substantial morbidity still occurs, especially in patients who have an otherwise normal pancreas. Methods: Between January 1990 and June 1997, 36 mucinous cystadenomas of the pancreas were resected at The Johns Hopkins Hospital. Most of these patients underwent ...
A 53-yr-old woman with a history of hepatic cystadenoma 25 yr before presented with a simple hepatic cyst, which evolved over 9 yr into a complex cystadenoma with septations and internal bleeding. She was treated with a left hepatectomy. Review of the literature shows that hepatic cystadenomas, although rare, frequently can recur years later and have potential for malignant transformation. Histologic similarities of one variant with ovarian stroma raises interesting possibilities regarding the origin of these lesions. The best treatment results are obtained with radical excision ...
Epigenetic aberrations have been shown to be intimately associated with ovarian tumorigenesis (10, 11). A number of genes including the classic tumor suppressor, BRCA1, p16, MLH1, RASSF1A, ANGPTL2, ARH1, LOT1, ICAM1, HSulf-1, PALB2, and TUBB3 have been shown to be hypermethylated and downregulated in ovarian cancer (11). In the present study, we showed that downregulation of FILIP1L (previously termed DOC1) is associated with DNA methylation in ovarian cancer. We have shown that both the mRNA and protein expression of FILIP1L are downregulated in ovarian cancer cells. FILIP1L expression is significantly lower in invasive serous carcinoma than in noninvasive serous borderline tumors. FILIP1L expression is inversely correlated with the invasive potential of ovarian cell lines as well as clinical ovarian specimens. The CpG island in the FILIP1L promoter is heavily methylated in ovarian cancer cells and almost completely nonmethylated in normal HOSE cells. The DNA methylation status of the FILIP1L ...
Tumor-infiltrating neutrophil (TIN) has been reported to be an independent predictor in multiple tumors, but its role in the development of adenocarcinoma of the esophagogastric junction (AEG)...
NAD(P)H:quinone oxidoreductase (NQO1) is a flavoprotein that catalyzes two-electron reduction and detoxification of quinones and its derivatives. NQO1 catalyzes reactions that have a protective effect against redox cycling, oxidative stress and neoplasia. High expression of NQO1 is associated with many solid tumors including those affecting the colon, breast and pancreas; however, its role in the progression of ovarian carcinoma is largely undefined. This study aimed to investigate the clinicopathological significance of high NQO1 expression in serous ovarian carcinoma. NQO1 protein expression was assessed using immunohistochemical (IHC) staining in 160 patients with serous ovarian carcinoma, 62 patients with ovarian borderline tumors and 53 patients with benign ovarian tumors. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect NQO1 mRNA expression levels. The correlation between high NQO1 expression and clinicopathological features of ovarian carcinoma was evaluated by
Dishevelled family proteins (DVL1, DVL2 and DVL3) are cytoplasmic mediators involved in canonical and non-canonical Wnt signaling that are important for embryonic development. Since Wnt signaling promotes cell proliferation and invasion, its increased activation is associated with cancer development as well. To get deeper insight into the behavior of Dishevelled proteins in cancer, we studied their expression in serous ovarian carcinomas [both low- (LGSC) and high-grade (HGSC)], and HGSC cell lines OVCAR5, OVCAR8 and OVSAHO. DVL protein expression in serous ovarian carcinomas tissues was analyzed using immunohistochemistry while DVL protein and mRNA expressions in HGSC cell lines were analyzed using western blot and quantitative real-time PCR. DVL1 protein expression was significantly higher in LGSC compared with normal ovarian tissue, while DVL3 was overexpressed in both LGSC and HGSC. DVL2 and DVL3 protein expression was higher in HGSC cell lines when compared with normal control cell line ...
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020 Jan 11;:109539 Authors: El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein G Abstract High-grade serous ovarian carcinoma (HGSOC) is the mos...
TY - JOUR. T1 - The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia Prepared by. AU - ASGE Standards of Practice Committee. AU - Eloubeidi, Mohamad A.. AU - Decker, G. Anton. AU - Chandrasekhara, Vinay. AU - Chathadi, Krishnavel V.. AU - Early, Dayna S.. AU - Evans, John A.. AU - Fanelli, Robert D.. AU - Fisher, Deborah A.. AU - Foley, Kimberly. AU - Hwang, Joo Ha. AU - Jue, Terry L.. AU - Lightdale, Jenifer R.. AU - Pasha, Shabana F.. AU - Saltzman, John R.. AU - Sharaf, Ravi. AU - Shergill, Amandeep K.. AU - Cash, Brooks D.. AU - DeWitt, John M.. PY - 2016/1/1. Y1 - 2016/1/1. N2 - This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this document that updates a previously issued consensus statement and a technology status evaluation report on this topic.1 In preparing this guideline, a search ...
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
Surgical resection of borderline epithelial ovarian tumors (costs for program #130589) ✔ University Hospital Giessen UKGM ✔ Department of Gynecology and Obstetrics ✔ BookingHealth.com
美国,旧金山,洛杉矶,纽约,生活,华人,中文,百科知识,移民,租房,买房,保险,汽车,招聘,求职,求助,租车,保姆,月嫂,家政,用工
Home / Research / Super-heavy pyrite (δ 34Spyr , δ 34SCAS) in the terminal Proterozoic Nama Group, Southern Namibia: A consequence of low seawater sulfate at the dawn of animal life ...
See also ; ovarian tumors Appearance : ovarian epithelial tumors ovarian serous tumors benign ovarian serous tumors proliferating (...)
https://doi.org/10.18632/oncotarget.21175 Véronique DHondt, Magalie Lacroix-Triki, Marta Jarlier, Florence Boissiere-Michot, Carole Puech, Peter Coopman, Dionyssios Katsaros, Gilles Freiss
To determine the prognosis and prognostic factors in a large series of mucinous borderline tumors of the ovary (MBOT).A retrospective review of patients with ...
A psammoma body is a round collection of calcium, seen microscopically. The term is derived from the Greek word ψάμμος (psámmos), meaning sand. Psammoma bodies are associated with the papillary (nipple-like) histomorphology and are thought to arise from (1) the infarction and calcification of papillae tips and (2) calcification of intralymphatic tumor thrombi. Psammoma bodies are commonly seen in certain tumors such as: Papillary thyroid carcinoma Papillary renal cell carcinoma Micropapillary subtype of lung adenocarcinoma Ovarian papillary serous cystadenoma and cystadenocarcinoma Endometrial adenocarcinomas (Papillary serous carcinoma ~3%-4%) Meningiomas, in the central nervous system Peritoneal and Pleural Mesothelioma Somatostatinoma (pancreas) Prolactinoma of the pituitary ... Psammoma bodies may be seen in: Endosalpingiosis Psammomatous melanotic schwannoma Melanocytic nevus Psammoma bodies usually have a laminar appearance, are circular, acellular and basophilic. Johannessen JV, ...
Histologically, cystoadenomas are characterised by the presence of cysts lined with mucinous cuboidal or columnar epithelium.6 An ovarian-type stroma is seen in 85% of cases and exclusively in females.4 A marsupial pseudocapsule separates the cystadenoma from the biliary epithelium.4 Elevated levels of CA 19-9 and/or CEA have been reported within the cysts themselves.1 2 4 11 12. Although the biliary cystadenoma is a benign entity, malignant transformation can occur, leading to cystadenocarcinoma.4 Sarcomatous transformation has also been described in one case.6 It has been suggested that cystadenocarcinomas arising from biliary cystadenomas with ovarian-type stroma have a relatively indolent course, whereas cystadenomas without ovarian-type stroma have a poorer prognosis.4. Most commonly, on radiologic imaging, these neoplasms appear as multi-loculated, multi-septated intrabiliary neoplasms. They are usually large at the time of presentation, with a mean tumour size of 15 centimetres.4 On CT, ...
Symptoms. Mucinous Cystadenocarcinomas are more common in the body and tail of the pancreas. They can be more prominent then 10 centimeters. Guess with this kind of pancreatic cancer for the most part better. Pancreatoblastomas are uncommon (0.5 percent) exocrine tumors commonly found in children under 10 years of age, however it can happen all through lifetime. Pancreatoblastomas are recognized all the more regularly in guys and Asians. They show up as a group of cells among ordinary cells. Survival is superior to with adenocarcinoma.. Serous Cystadenomas are ordinarily kindhearted tumors. They have a wipe like improvement and can be cumbersome. They are loaded with watery fluid, while mucinous cystadenomas are loaded with a thicker sticky liquid. Serous cystadenomas comprise of single or different growths averaging 5-8 cm and upwards to 25 cm in breadth. Papillary Tumors are uncommon with an inclination for young ladies principally between 19 - 50 years of age. It is a huge round very much ...
Biliary cystadenomas are benign but potentially malignant cystic neoplasms, which classically contain mesenchymal stroma similar to ovarian tissue. We report a case of an extra-hepatic biliary cystadenoma with mesenchymal stroma along with a discussi
The TP53 gene mutation frequency in ovarian serous carcinomas has been reported to range between 50% and 80%. A research team working at the The Sidney Kimmel Comprehensive Cancer Center of The Johns Hopkins Medical Institutions (Johns Hopkins) made several important findings regarding TP53 gene mutations with respect to high grade ovarian serous carcinoma, as reported in the International Journal of Gynecological Cancer. Ovarian serous carcinoma is the most common tumor subtype within the epithelial ovarian cancer histological classification.. According to the Johns Hopkins research team, a stringent analysis of the TP53 gene using purified epithelial tumor samples has not been performed to accurately assess the TP53 gene mutation frequency and its correlation to tumor histologic grade. The research team assessed the TP53 gene mutational profile in a relatively large series of high-grade (53 primary tumors and 18 recurrent tumors) and 13 low-grade ovarian serous tumors. All samples were ...
The TP53 mutation frequency in ovarian serous carcinomas has been reported to range between 50% and 80%, but a stringent analysis of TP53 using purified epithelial samples has not yet been performed to accurately assess the mutation frequency and to correlate it with the histologic grade. The purpose of this study was to assess the TP53 mutational profile in a relatively large series of high-grade (53 primary and 18 recurrent) and 13 low-grade ovarian serous tumors using DNA isolated from affinity-purified tumor cells and to correlate it with in vitro drug resistance. All samples were affinity purified, and the tumor DNA was analyzed for TP53 mutations in exons 4-9. In vitro drug resistance assays to carboplatin, cisplatin, paclitaxel, and taxotere were performed on the same tumor samples and correlated with the TP53 mutation status. TP53 mutations were detected in 57 (80.3%) of 71 high-grade carcinomas and in one (7.8%) of 13 low-grade serous tumors (an invasive low-grade serous carcinoma). The ...
Robot-Assisted Laparoscopic Vesiculectomy for Large Seminal Vesicle Cystadenoma: A Case Report and Review of the Literature. ( 25862321 ) ...
1. Cadron, I., Leunen, K., Van Gorp, T., et al. Management of borderline ovarian neoplasms. J Clin Oncol, 2007, 25, p. 2928-2937. 2. Chambers, JT., Merino, MJ., Kohorn, EI., Schwartz, PE. Borderline ovarian tumors. Am J Obstet Gynecol, 1988, 159, p. 1088-1094. 3. Darai, E., Fauvet, R., Uzan, C., et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update, 2013, 19, p. 151-166. 4. Fauvet, R., Boccara, J., Dufourmet, C., et al. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol, 2005, 16, p. 403-410. 5. Hoskins, PJ. Ovarian tumors of low malignant potential: borderline epithelial ovarian carcinoma. In Lawton, FG., Neijt, JP., Swenerton, KD. (eds) Epithelial cancer of the ovary. London: BMJ Publishing Group. 1995, p. 112-136. 6. Kaern, JT., Trope, CG., Abeler, VM. A retrospective study of 370 borderline tumours of the ovary treated at the Norwegian ...
Borderline epithelial ovarian tumors Diagnosis (costs for program #248705) ✔ University Hospital Halle (Saale) ✔ Department of Gynecology and Mammology ✔ BookingHealth.com
Low grade serous ovarian cancer affects approximately 1 in 1000 women, many will be diagnosed in their 20s and 30s. With current medical treatments ...
Risk of Malignancy in Unilocular Ovarian Cystic Tumors Less Than 10 Centimeters in Diameter Susan C. Modesitt, MD, Edward J. Pavlik, PhD, Frederick R. Ueland, MD, Paul D. DePriest, MD, R. J. Kryscio, PhD,
Hi all, I am cross posting this since I think I initially posted to the wrong forum. I had what my dr. though were 2 dermoid cysts (one one each ovary). I had a laproscopic procedure to remove bo...
Tseng JF (March 2008). "Management of serous cystadenoma of the pancreas". J. Gastrointest. Surg. 12 (3): 408-10. doi:10.1007/ ...
Pancreatic mucinous cystic neoplasm Pancreatic serous cystadenoma Solid pseudopapillary neoplasm "Intraductal Papillary ... Next, the investigators tested harmless cysts such as serous cystadenomas, and the harmless cysts did not have GNAS or KRAS ...
Solid pseudopapillary neoplasm Pancreatic serous cystadenoma Intraductal papillary mucinous neoplasm Theruvath TP, Morgan KA, ...
revdel) Pancreatic serous cystadenoma. *(speedy) User:Amaitra1/Serous cystic neoplasms. *(request speedy, got stubify) ...
See pancreatic tumors, benign or malignant (pancreatic cancer). Serous cystadenoma of the pancreas Solid pseudopapillary ...
... known as chocolate cysts Hemorrhagic ovarian cyst Dermoid cyst Ovarian serous cystadenoma Ovarian mucinous cystadenoma ...
Cystadenoma (mucinous/serous) Cystadenocarcinoma Islet cell tumors (neuroendocrine tumors) Papillary cystic neoplasms Lymphoma ...
... pancreatic serous cystadenoma), endolymphatic sac tumor, and bilateral papillary cystadenomas of the epididymis (men) or broad ...
... carcinoma Papillary renal cell carcinoma Micropapillary subtype of lung adenocarcinoma Ovarian papillary serous cystadenoma and ... Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer ... cystadenocarcinoma Endometrial adenocarcinomas (Papillary serous carcinoma ~3%-4%) Meningiomas, in the central nervous system ...
Pancreatic serous cystadenoma Pancreatic serous cystadenocarcinoma Pancreatic mucinous cystic tumors (13.4%) Pancreatic ... Pancreatic intraductal papillary mucinous tumors (most common diagnosis - 52.6%) Pancreatic serous cystic tumors (20.6%) ... mucinous cystadenoma Pancreatic mucinous cystadenocarcinoma Parra-Herran, C. E.; Garcia, M. T.; Herrera, L; Bejarano, P. A. ( ...
Primary splenic artery aneurysm ruptured into pancreatic serous cystadenoma. Turk J Gastroenterol 19:57-63 (2008) 40. Mungan Z ...
ISBN 1-4160-2999-0. Picture of serous cystadenoma Serous cystadenoma of pancreas at eMedicine Biliary cystadenoma/ ... serous cystadenoma (8441-8442) papillary cystadenoma (8450-8451, 8561) mucinous cystadenoma (8470-8473) Bile duct cystadenoma ( ... 8161) Endometrioid cystadenoma (8380) Appendiceal mucinous cystadenoma The term "cystadenoma" may also refer to a hidrocystoma ... Cystadenoma (or "cystoma") is a type of cystic adenoma. When malignant, it is called cystadenocarcinoma. When not otherwise ...
... majority of microcystic pancreatic masses representing alternate disease processes such as the more benign serous cystadenoma. ... Serous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. Most commonly the primary site of serous ... August 2005). "Serous cystadenocarcinoma of the pancreas: management of a rare entity". Pancreas. 31 (2): 182-7. doi:10.1097/01 ... 13(10):1864-8 (2009 month=October). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". Check ...
Sixty percent are benign (cystadenoma), 10% are borderline and 30% are malignant (cystadenocarcinoma). Benign serous tumours ... Malignant serous tumours are solid, may be cystic and often show haemorrhage and necrosis. They are lined by a complex ... Serous tumours are part of the surface epithelial-stromal tumour group of ovarian neoplasms, which derive from Mullerian ... Serous carcinomas often have bulky peritoneal and omental metastases, and spread to the lymph nodes is frequent. Unsurprisingly ...
Serous tumour Cytopathology Ovarian serous cystadenoma Mesothelioma Serous Membranes & Cavities Lecture. Veterinary Anatomy Web ... Uterine serous carcinoma, also known as uterine papillary serous carcinoma, a type of uterine cancer. Fallopian tube serous ... Cervical serous carcinoma, a rare type of cervical cancer. Primary peritoneal serous carcinoma, a very rare cancer that arise ... a serous cavity). Serous lined cavities include the peritoneum, pericardium and pleural space and tunica vaginalis. Cytologic ...
... may refer to: Ovarian serous cystadenoma, a very common benign tumour of the ovary. Pancreatic serous ... cystadenoma, also known as serous microcystic adenoma.. ...
Papillary serous cystadenoma Papillary serous cystadenocarcinoma of the ovary images: [1] Kosary, Carol L. (2007). "Chapter 16 ... Papillary serous cystadenocarcinomas are the most common form of malignant ovarian cancer making up 26 percent of ovarian ... Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer ... Papillary serous cystadenocarcinomas may exhibit psammoma bodies upon histopathology. ...
... , also known as serous cystadenoma of the pancreas and serous microcystic adenoma, a benign tumour ... Ovarian serous cystadenoma Pancreatic mucinous cystadenoma Solid pseudopapillary neoplasm Colonna, J.; Plaza, JA.; Frankel, WL ... Those that are benign, that have not spread to other organs, are designated "serous cystadenoma". Serous cystadenomas can be ... 2008). "Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients". Pancreatology. 8 (2): 135-41. ...
... , also (less precisely) known as serous cystadenoma, is the most common ovarian neoplasm, ... also called serous borderline tumours, that may transform into serous carcinoma. Serous cystadenomas (of the ovary) are not ... Ovarian cancer Pancreatic serous cystadenoma Serous carcinoma Human Reproduction. University of Utah Medpath http://library.med ... serous carcinoma), and (2) does not share genetic traits of indeterminate serous tumours, ...
It includes serous tumour, endometrioid tumor, and mucinous tumour. They can be benign (cystadenoma) or malignant ( ...
... is a group of tumors. An example is cystadenoma. Cyst Mucinous, Mucous gland Serous, ...
... types Serous tumor of borderline malignancy Serous carcinoma Well differentiated endometrioid tumor Mucinous cystadenoma ... structures Adenomatoid tumor Malignant and Benign Mesothelioma Adenocarcinoma of the epididymis Papillary cystadenoma of the ...
... cystadenoma (serous or mucinous), diverticular or appendiceal abscess, nerve sheath tumor, pelvic kidney, ureteral or bladder ... Serous carcinomas are thought to begin in the Fallopian tube. Histologically, serous adenocarcinomas have psammoma bodies. Low- ... Serous carcinomas may develop from serous tubal intraepithelial carcinoma, rather than developing spontaneously from ovarian ... Low-grade serous carcinoma is less aggressive than high-grade serous carcinomas, though it does not typically respond well to ...
... serous MeSH C04.557.470.590.485 --- cystadenoma MeSH C04.557.470.590.485.225 --- cystadenoma, mucinous MeSH C04.557.470.590. ... cystadenoma, papillary MeSH C04.557.470.035.320.240 --- cystadenoma, serous MeSH C04.557.470.035.415 --- growth hormone- ... 485.230 --- cystadenoma, papillary MeSH C04.557.470.590.485.240 --- cystadenoma, serous MeSH C04.557.470.590.580 --- ... cystadenoma MeSH C04.557.470.035.320.225 --- cystadenoma, mucinous MeSH C04.557.470.035.320.230 --- ...
Mucinous cystadenoma of the pancreas Mucinous cystadenoma Pancreatic cysts Pancreatic serous cystadenoma Parra-Herran, C. E.; ... Mucinous cystadenoma of the pancreas Mucinous cystadenoma of the pancreas Mucinous cystadenoma of the pancreas ... Pancreatic mucinous cystadenoma, also known as "mucinous cystadenoma of the pancreas", is a benign tumour of pancreas. It is ...
Ovarian serous cystadenoma. *Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor ...
Ovarian serous cystadenoma. *Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor ...
Ovarian serous cystadenoma. *Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor ...
NOS M8441/0 Serous cystadenoma, NOS Serous cystoma Serous microcystic adenoma M8441/3 Serous cystadenocarcinoma, NOS (C56.9) ... Serous adenocarcinoma, NOS Serous carcinoma, NOS M8442/1 Serous cystadenoma, borderline malignancy (C56.9) Serous tumor, NOS, ... M8460/0 Papillary serous cystadenoma, NOS (C56.9) M8460/3 Papillary serous cystadenocarcinoma (C56.9) Papillary serous ... M8462/1 Serous papillary cystic tumor of borderline malignancy (C56.9) Papillary serous cystadenoma, borderline malignancy ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Papillary serous cystadenocarcinoma "Female Genital Pathology". Retrieved 2009-03-23. King JC, Ng TT, White SC, Cortina G, ... Cystadenocarcinoma is a malignant form of a cystadenoma and is a malignant neoplasm derived from glandular epithelium, in which ... Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. Similar tumor ... Reber HA, Hines OJ (October 2009). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". J ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Serous(英语:Serous gland). *卵巢浆液性囊腺瘤 / Pancreatic serous cystadenoma(英语:Pancreatic serous cystadenoma) / Serous ... 囊性肿瘤: 浆液性微囊性腺癌(英语:Serous microcystic adenoma) ... cystadenocarcinoma(英
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
... pancreatic serous cystadenoma),此類幾乎都為良性,除此之外還有另外三種病理狀態: ... 囊性腫瘤
Later the rash becomes vesicular, forming small blisters filled with a serous exudate, as the fever and general malaise ... Papillary cystadenoma lymphomatosum. *Pleomorphic adenoma. *Sebaceous adenoma. *Malignant: Acinic cell carcinoma. * ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ... Warthin's tumor, also known as papillary cystadenoma lymphomatosum, is a benign cystic tumor of the salivary glands containing ...
Serous. *Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous ...
Pancreatic serous cystadenoma, also known as serous cystadenoma of the pancreas and serous microcystic adenoma, a benign tumour ... Ovarian serous cystadenoma Pancreatic mucinous cystadenoma Solid pseudopapillary neoplasm Colonna, J.; Plaza, JA.; Frankel, WL ... Those that are benign, that have not spread to other organs, are designated "serous cystadenoma". Serous cystadenomas can be ... 2008). "Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients". Pancreatology. 8 (2): 135-41. ...
What causes an ovarian serous cystadenoma to rupture do I need surgery if rupture? Pressure. The increased pressure and weak ... serous cystadenoma until it is surgically removed and examined by a pathologist. Benign serous cystadenoma is a pathological ... Possible: Serous cystadenoma has a benign and malignant form called serous cystadenocarcinoma of the ovary. The pathologic ... If I have a benign serous cystadenoma and it rupture during surgery can it still be examined to know if it is serous ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
The biopsy reported a benign serous cystadenoma. At a 1-year follow-up, the child is asymptomatic and ovarian preservation was ... Robotic assisted ovary preserving excision of a benign serous cystadenoma in a prepubertal symptomatic girl ... Robotic assisted ovary preserving excision of a benign serous cystadenoma in a prepubertal symptomatic girl ...
... pseudomucinous or serous cystadenoma, or dermid) or malignant (carcinoma).. BK: DISEASES. RK: NEOPLASMS. Send Comments About ...
Abdominal Pain was commonest symptom.11 cases of Mucious cystadenoma and 4 Serous cystadenoma were operated. 11 Distal ...
Lev parallel foozling your silhouetting muss intravenously? Lard clitic Gleaning unconditionally? Forty serous cystadenoma ...
Serous cystadenoma may refer to: Ovarian serous cystadenoma, a very common benign tumour of the ovary. Pancreatic serous ... cystadenoma, also known as serous microcystic adenoma.. ...
Serous cystadenomas are multilocular. In some instances, they include papillary projections. Giant ovarian serous cyst adenoma ... Serous tumors secrete serous fluids and are originated by invagination of the surface epithelium of ovary. Serous tumors are ... A Postmenopausal Woman with Giant Ovarian Serous Cyst Adenoma: A Case Report with Brief Literature Review. Nishat Fatema and ... Huge size ovarian serous cystadenoma is rare. In the literature, a few cases of giant ovarian cysts have been mentioned ...
Pathological specimen reveals ovarian serous cystadenoma. DWI can provide an adjunctive tool to differentiate the benign and ... Pathological specimen reveals ovarian serous cystadenoma.. DWI can provide an adjunctive tool to differentiate the benign and ...
... of all serous tumours. Epidemiology They present at a younger age group 1-2 than the more malignant s... ... Borderline ovarian serous cystadenomas lie in the intermediate range in the spectrum of ovarian serous tumours and represent ... Borderline ovarian serous cystadenoma. Dr Bruno Di Muzio ◈ and Dr Yuranga Weerakkody ◉ et al. ... Borderline ovarian serous cystadenomas lie in the intermediate range in the spectrum of ovarian serous tumours and represent ...
Serous cystadenoma of pancreas is a benign tumor of pancreas. The size of tumor is usually small. Usually it does not produce ... Treatment Of Serous Cystadenoma Of Pancreas. Pancreatic serous cystadenoma is typically small and benign tumor. A giant serous ... Signs And Symptoms Of Serous Cystadenoma Of Pancreas. The signs and symptoms of serous cystadenoma of pancreas depend on its ... Serous Cystadenoma Of Pancreas Complications. Normally there are no complications associated with serous cystadenoma of ...
Most common symptoms of serous cystadenomas of the pancreas are pain in the abdomen, jaundice, nausea and vomiting, a mass in ... Risk Factors For Serous Cystadenoma Of Pancreas. *The precise causative factor for serous cystadenoma of the pancreas is ... Symptoms Of Serous Cystadenoma Of Pancreas. *The most common symptoms of serous cystadenomas of the pancreas are - pain in the ... Treatment Of Serous Cystadenoma Of Pancreas. *Since there is considerable overlapping in the imaging findings of serous and ...
Keywords: benign serous cystadenoma, coexistence of benign serous cystadenoma and tuberculosis, ovarian caseous necrosis, ... We report a case of coexisting ovarian serous cystadenoma and tuberculosis in a 29-year-old Indian woman. Clinical examination ... Coexistence of benign ovarian serous cystadenoma and tuberculosis in a young woman. ... Coexistence of benign ovarian serous cystadenoma and tuberculosis in a young woman ...
Serous Cystadenoma - Ovary. by Dr Vijay Shankar S , May 23, 2016 , Female Genital System & Breast, Practical Pathology, Slides ... Serous cystadenoma- ovary. Gross : unilocular cyst of varying size. The external surface will be smooth and glistening. It ... contains clear serous fluid. The internal surface will also be smooth. Papillary excrescences can be seen at times ...
Serous papillary cystadenoma is a fairly common benign tumor of the ovary. It is known to affect women in the age group of 40 ... Risk Factors For Serous Papillary Cystadenoma. The precise cause for the occurrence of the occurrence of serous papillary ... Serous Papillary Cystadenoma Of Ovary: Symptoms & Management Salina Womens Health March 16, 2017. March 15, 2017. ... Serous papillary cystadenoma is a fairly common benign tumor of the ovary which is known to affect women in the age group of 40 ...
Serous cystadenoma, may refer to: , , ,,Ovarian serous cystadenoma,, a very common ,benign... World Heritage Encyclopedia, the ... Ovarian serous cystadenoma, a very common benign tumour of the ovary. *Pancreatic serous cystadenoma, also known as serous ... Ovarian serous cystadenoma Encyclopedia Article. H&E stain, International Classification of Diseases for Oncology, Medical ...
Symptoms of serous cystadenoma. The Symptoms of serous cystadenoma of the ovary is directly dependent on its size. With this ... Diagnosis of serous cystadenoma. Serous cystadenoma well seen with ultrasound examination. On the ultrasound screen she looks ... Simple serous cystadenoma.. This ovarian cyst has different names - simple serous cystadenoma solid wall reliabilily cyst, ... Causes of serous cystadenoma. The causes of serous cistadenomy still to be confirmed. Most scientists agree on the idea that ...
Panchagnula R, Rameshkumar K. Microcystic serous cystadenoma mimicking malignancy in pancreas. Journal of the Association of ...
Ovarian serous cystadenoma was confirmed by pathology evaluation. Pregnancy passed normally until the delivery of a 3100-gm ... A Giant Ovarian Serous Cystadenoma in Pregnancy: A Case Report. Article 14, Volume 6, Issue 4, October 2018, Page 1486-1490 PDF ... serous cystadenoma 17%, and mucinous cystadenoma 8%), and 3% malignant (i.e., low malignant potential or adenocarcinoma) (2). ... "A Giant Ovarian Serous Cystadenoma in Pregnancy: A Case Report". Journal of Midwifery and Reproductive Health, 6, 4, 2018, 1486 ...
Serous cystadenoma of ovary with xanthogranulomatous oophoritis: combination of benign ovarian tumour with chronic inflammatory ...
Histologically, the resected mass was not of tubal origin as suspected, but a serous cystadenoma arising from ovarian tissue. ... serous cystadenoma [10], serous cystadenofibroma [11], fibroma [12], and adenocarcinoma have been described. Common clinical ... Giant serous cystadenoma arising from an accessory ovary in a morbidly obese 11-year-old girl: a case report. *Steven M Sharatz ... We report a case of what is best described as a giant serous cystadenoma arising from an accessory ovary in a morbidly obese 11 ...
Chronic constipation: An unusual presentation of a Giant Serous Cystadenoma of ovary. ... Chronic constipation: An unusual presentation of a Giant Serous Cystadenoma of ovary. ...
... Author. Zvizdic, Zlatan. ... Zvizdic Z, Bukvic M, Murtezic S, Skenderi F, Vranic S, Giant paratubal serous cystadenoma in an adolescent female: Case report ... Giant paratubal serous cystadenoma in an adolescent female: Case report and literature review.. ... Histopathological examination was consistent with a serous cystadenoma. The postoperative course was uneventful and the girl ...
... ... Histopathological examination was consistent with a serous cystadenoma. The postoperative course was uneventful and the girl ... A complete excision of cystadenoma with preservation of adnexa represents a desirable treatment modality in adolescent females ...
Pathology report revealed serous cystadenoma. Existence of such cases can be an alarming sign for physicians to manage ... reported an ovarian serous cystadenoma in a young girl. Their patient had a one-year history of gradual abdominal swelling, ... Mülayim B, Gürakan H, Dagli V, Mülayim S, Aydin O, Akkaya H. Unaware of a giant serous cyst adenoma: a case report. Archives of ... Pathology report revealed serous cystadenoma. Existence of such cases can be an alarming sign for physicians to manage ...
Cystadenocarcinoma, Serous / surgery. Cystadenoma, Serous / diagnosis. Cystadenoma, Serous / surgery. Humans. *MedlinePlus ... serous cystadenoma (n = 20), serous borderline (n = 14), and serous ovarian cancer (n = 47) and was correlated in cancer cases ... Cystadenocarcinoma, Serous / chemistry. Cystadenoma, Serous / chemistry. Estrogen Receptor alpha / analysis. Ovarian Neoplasms ... Cystadenoma, Mucinous / epidemiology. Cystadenoma, Serous / epidemiology. Cystectomy. Female. Germinoma / epidemiology. Humans ...
Serous cystadenoma (SCA) Also known as microcystic adenomas, serous cystadenomas do not have malignant potential. Therefore, ... The diagnosis of a serous cystadenoma can be made with confidence when a lesion demonstrates the classic imaging appearance of ... including a pseudocyst and serous cystadenoma. The fluid aspirated will contain thick mucin and an elevated level of tumor ...
Johnson JR, Lee C, Carnett S, Vadakekut E. Laparoscopic management of enlarged serous cystadenoma in advanced pregnancy. ... Laparoscopic management of enlarged serous cystadenoma in advanced pregnancy. Joseph R. Johnson, Chris Lee, S. Carnett, E. ... Laparoscopic management of enlarged serous cystadenoma in advanced pregnancy. / Johnson, Joseph R.; Lee, Chris; Carnett, S.; ... Johnson, J. R., Lee, C., Carnett, S., & Vadakekut, E. (2007). Laparoscopic management of enlarged serous cystadenoma in ...
Characterization of Pancreatic Serous Cystadenoma on Dual-Phase Multidetector Computed Tomography. Chu, Linda C.; Singhi, Aatur ...
Epididymal papillary cystadenoma. *Pancreatic serous cystadenomas. *Pancreatic neuroendocrine tumors. Why should those at risk ...
Solid Appearance of Pancreatic Serous Cystadenoma Diagnosed as Cystic at Ultrasound Acoustic Radiation Force Impulse Imaging, ... typical of a microcystic serous cystadenoma (Figure 3c).. DISCUSSION. Serous cystadenoma is a benign cystic tumor of the ... serous cystadenoma) and more complex (i.e. mucinous cystadenoma, necrosis, intraductal-papillary mucinous tumors and endocrine ... We present the first case of pancreatic serous cystadenoma which mimics a solid neoplasm at conventional imaging (US and CT), ...
Serous cystadenoma (also known as serous cystic neoplasm). Serous cystadenomas (SCAs) are non-cancerous cysts. They may be ...
  • In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost always entirely benign. (wikipedia.org)
  • rare case reports have described isolated malignant serous cystadenocarcinomas. (wikipedia.org)
  • either benign (pseudomucinous or serous cystadenoma, or dermid) or malignant (carcinoma). (popline.org)
  • In addition, serous cystic neoplasms slowly grow, and if they grow large enough they can press on adjacent organs and cause symptoms. (wikipedia.org)
  • Pathologists classify serous cystic neoplasms into two broad groups. (wikipedia.org)
  • Serous cystic neoplasms can come to clinical attention in a variety of ways. (wikipedia.org)
  • Once a doctor has reason to believe that a patient may have serous cystic neoplasm, he or she can confirm that suspicion using one of a number of imaging techniques. (wikipedia.org)
  • Pancreatic serous cystadenoma, also known as serous cystadenoma of the pancreas and serous microcystic adenoma, a benign tumour of pancreas. (wikipedia.org)
  • In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost always entirely benign. (wikipedia.org)
  • Serous cystadenoma of pancreas is a benign tumor of pancreas. (tandurust.com)
  • Serous cystadenoma of pancreas is mainly present in women, especially over the age of 60 years. (tandurust.com)
  • Serous cystadenoma of pancreas is an uncommon form of cystic tumor of pancreas. (tandurust.com)
  • The particular risk factors for development of serous cystadenoma of pancreas is not known, but common risk factors that attribute development of any pancreatic tumor are also suspected to be the cause. (tandurust.com)
  • The signs and symptoms of serous cystadenoma of pancreas depend on its size. (tandurust.com)
  • The serous cyst is present in either tail or body of pancreas. (tandurust.com)
  • Serous cystadenoma of pancreas is well demarcated tumor. (tandurust.com)
  • Normally there are no complications associated with serous cystadenoma of pancreas. (tandurust.com)
  • If there is a giant sized serous cystadenoma of pancreas which adheres or infiltrates the nearby tissues causing symptoms, it may need to be removed through complete surgical excision of the growth. (tandurust.com)
  • Distinct from some of the other cyst forming neoplasms of the pancreas, serous cystic neoplasms are usually entirely benign. (simple-remedies.com)
  • The precise causative factor for serous cystadenoma of the pancreas is unknown. (simple-remedies.com)
  • The most common symptoms of serous cystadenomas of the pancreas are - pain in the abdomen, a sensation of fullness, jaundice, nausea and vomiting, a mass in the abdomen, and fatigue. (simple-remedies.com)
  • IMSEAR at SEARO: Microcystic serous cystadenoma mimicking malignancy in pancreas. (who.int)
  • Macrocystic serous cystadenoma of the pancreas masquerading as a mucinous cystadenoma: case report]. (qxmd.com)
  • Serous cystadenoma (SCA) is a rare, benign neoplasm that originates in the centro-acinar epithelium of the pancreas. (jpatholtm.org)
  • Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). (maunakeatech.com)
  • Risk of malignancy in serous cystic neoplasms of the pancreas. (nih.gov)
  • Malignant serous cystic neoplasm of the pancreas: report of a case and review of the literature. (nih.gov)
  • Serous Microcystic Adenocarcinoma of Pancreas Infiltrating Into Spleen: A Case Report. (nih.gov)
  • A rare case of serous cystadenocarcinoma of the pancreas. (nih.gov)
  • Serous cystadenocarcinoma of the pancreas with portal thrombosis. (nih.gov)
  • Further imaging-based characterization of the possible histopathology of lesion may help in differentiating a benign pseudocyst from a cystic tumor of the pancreas, a mucinous cystic tumor from a serous tumor, and a neuroendocrine tumor from other solid neoplasias may help in determination of resectability of each of these pancreatic lesions. (springer.com)
  • Serous Cystadenoma at the tail of the pancreas is not uncommon. (sages.org)
  • The case presented demonstrates a minimally invasive approach for splenic vessels- and spleen-preserving distal pancreatectomy for serous cystadenoma at the tail of the pancreas with highlighted steps of the procedure. (sages.org)
  • A serous cystadenoma is a benign cyst that can arise anywhere in the pancreas. (moffitt.org)
  • Microcystic (serous) pancreatic cystadenoma (plus insular pancreas). (humpath.com)
  • Lesions of the pancreas are fairly common leading to the occurrence of simple cysts, serous cystadenoma or solid tumors. (ipl.org)
  • Some tumors of the pancreas, including the serous cystadenoma and mucinous cystadenocarcinomas are cystic. (jhu.edu)
  • Cystadenoma, adenofibroma, and surface papillomas are the benign serous tumors. (hindawi.com)
  • These tumors occur in about 25% of all benign ovarian neoplasms and 58% of all ovarian serous tumors [ 2 ]. (hindawi.com)
  • Serous tumors are commonly seen during the reproductive period and 50% of them occur before the age of 40 years. (hindawi.com)
  • Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. (radiopaedia.org)
  • Serous cystadenomas are benign tumors which are composed of small cystic spaces that are lined by tiny cuboidal cells containing glycogen. (simple-remedies.com)
  • Obese people are known to develop serous tumors. (simple-remedies.com)
  • Since there is considerable overlapping in the imaging findings of serous and mucinous pancreatic tumors, these tumors need to be followed up with close watch via CT scans to evaluate the interval growth in case aspiration has not been carried out. (simple-remedies.com)
  • Our results demonstrate that K-ras mutations occur in approximately 50% of serous borderline tumors (SBTs), non-invasive micropapillary serous carcinomas (MPSCs), and invasive micropapillary serous carcinomas, which represent a morphological continuum of tumor progression. (nih.gov)
  • Moreover, progressive increase in the degree of allelic imbalance of chromosomes 1p, 5q, 8p, 18q, 22q, and Xp was observed comparing serous borderline tumors to noninvasive and invasive micropapillary serous carcinomas. (nih.gov)
  • In contrast, high-grade (conventional serous carcinoma) tumors contained wild-type K-ras in all 23 cases studied and a high frequency of allelic imbalance even in small (early) primary tumors similar to that found in advanced stage tumors. (nih.gov)
  • Several authors have reported frequent admixtures of clear cell ovarian carcinoma with serous, mucinous, and endometrioid tumors. (clinicaltrials.gov)
  • Non-invasive tumors that display greater epithelial proliferation and cytological atypia than benign serous tumors but less than low-grade serous carcinoma (LGSC). (jhu.edu)
  • Analysis of Smad3 nuclear expression in microarrays of serous benign tumors, borderline tumors, and cystadenocarcinoma revealed that Smad3 expression could be used to distinguish benign and borderline tumors from carcinoma ( P = 0.006). (aacrjournals.org)
  • In a subset of cases, washings can be diagnostically challenging due to the presence of co-existing benign cells (e.g., mesothelial hyperplasia, endosalpingiosis, or endometriosis), lesions in which there is only minimal atypia (e.g., serous borderline tumors) or scant atypical cells, and the rarity of specific tumor types (e.g., mesothelioma). (cytojournal.com)
  • Granulosa cell tumors, primary ovarian carcinoma such as mucinous and serous cystadenocarcinoma, and undifferentiated adenocarcinoma were the most prevalent malignant masses. (news-medical.net)
  • Amongst benign tumors, serous cystadenoma was the most frequent subtype, while for the malignant tumors serous cystadenocarcinoma was the commonest. (thefreelibrary.com)
  • Serous cystadenomas can be further sub-typed into microcystic, oligocystic (or macrocystic), solid, mixed serous-endocrine neoplasm, and VHL-associated serous cystic neoplasm. (wikipedia.org)
  • Borderline ovarian serous cystadenomas lie in the intermediate range in the spectrum of ovarian serous tumours and represent approximately 15% of all serous tumours. (radiopaedia.org)
  • Bilaterality occurs more frequently than with benign ovarian serous cystadenomas 1 . (radiopaedia.org)
  • With serous cystadenomas during this time, usually nothing happens. (allcysts.com)
  • Serous cystadenomas (SCAs) are non-cancerous cysts. (pancreaticcancer.org.uk)
  • Benign pancreatic serous cystadenoma usually is morphologically distinguishable from mucinous cystadenomas, which require resection because of their malignant potential. (qxmd.com)
  • The aim of this study was to determine the EUS and tumor marker characteristics of mucinous cystadenoma compared with macrocystic serous cystadenomas. (qxmd.com)
  • A resection specimen was available for 32 mucinous cystadenomas and 9 macrocystic serous cystadenomas. (qxmd.com)
  • Surveillance of serous cystadenomas is eliminated in 42% of cases. (maunakeatech.com)
  • The removal of some benign cysts, such as serous cystadenomas, may be beneficial if they are causing pain or other symptoms. (moffitt.org)
  • About 25% of adnexal growths are endometriomas, 33% are mature cystic teratomas, and the rest are functional cysts or serous or mucinous cystadenomas. (news-medical.net)
  • Pancreatic serous cystadenoma is typically small and benign tumor. (tandurust.com)
  • The tumor is considered the serous type based on its appearance when seen under the microscope. (simple-remedies.com)
  • In this scheme, low-grade OSC arises in a stepwise fashion from a benign serous cystadenoma through a usual serous borderline tumor through a micropapillary variant of serous borderline tumor. (nih.gov)
  • One theory, serous cistadenoma is formed functional ovarian cysts (follicular cyst of a yellow body). (allcysts.com)
  • And after about a year, the ability of functional cysts to spontaneous resorption is lost and is formed of serous cistadenoma. (allcysts.com)
  • Of these, 33% are non-neoplastic (luteal cysts), 63% benign (i.e., dermoid cyst 36%, serous cystadenoma 17%, and mucinous cystadenoma 8%), and 3% malignant (i.e., low malignant potential or adenocarcinoma) ( 2 ). (ac.ir)
  • The other pathway is characterized by rapid progression from the ovarian surface epithelium or inclusion cysts to a conventional (high-grade) serous carcinoma. (nih.gov)
  • These signs and symptoms are not specific for a serous cystic neoplasm, making it more difficult to establish a diagnosis. (wikipedia.org)
  • Once a doctor has reason to believe that a patient may have serous cystic neoplasm, he or she can confirm that suspicion using one of a number of imaging techniques. (wikipedia.org)
  • Ovarian serous cystadenoma Pancreatic mucinous cystadenoma Solid pseudopapillary neoplasm Colonna, J. (wikipedia.org)
  • Case report We present the first case of pancreatic serous cystadenoma which mimics a solid neoplasm at conventional imaging (US and CT), correctly diagnosed as cystic at ultrasound acoustic radiation force impulse imaging. (imedpub.com)
  • Expression of cyclooxygenase-2 in ovarian serous carcinoma: correlation with angiogenesis, nm23 expression and survival. (biomedsearch.com)
  • Ovarian serous carcinoma (OSC) is the most common ovarian epithelial malignancy. (nih.gov)
  • either benign (pseudomucinous or serous cystadenoma, or dermid) or malignant (carcinoma). (popline.org)
  • Of the various histological subtypes, high-grade serous carcinoma is the most common. (aacrjournals.org)
  • We propose that a similar mechanism occurs in ovarian carcinoma cells, although not readily appreciated because cells undergoing a mitotic arrest within an immortal cell culture, unlike in our mortal cystadenoma cells, are outgrown by a dividing cell population and therefore fail to accumulate. (aacrjournals.org)
  • We tested this hypothesis in SKOV3 cells, a high-grade serous ovarian carcinoma line known to be P53 deficient. (aacrjournals.org)
  • Diagnosis of serous cystadenoma must be made with complete caution. (simple-remedies.com)
  • Conclusion The "XXXX" values always measured at Virtual TouchTM tissue quantification allow the diagnosis of a pancreatic cystic lesion with simple fluid content suggesting the diagnosis of serous cystadenoma. (imedpub.com)
  • Ovarian cancer is thought to arise from neoplastic changes that result in the pathologic differentiation of OSE into the established histologic subtypes, which include serous (fallopian tube-like), endometrioid (endometrium-like), and mucinous (endocervical-like) adenocarcinoma among others. (aacrjournals.org)
  • rare case reports have described isolated malignant serous cystadenocarcinomas. (wikipedia.org)
  • They present at a younger age group 1-2 than the more malignant serous cystadenocarcinomas with a peak age of presentation of ~45 years of age 1 . (radiopaedia.org)
  • On the other hand, rare cases have been reported that have isolated malignant serous cystadenocarcinomas as well. (simple-remedies.com)
  • Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (wikipedia.org)
  • She underwent a liver resection, and histopathology confirmed a serous biliary cystadenoma. (uwi.edu)
  • OBJECTIVE: To evaluate the expression of cyclooxygenase (COX)-2 in ovarian serous carcinomas (OSC) and its correlation with microvessel density (MVD), nm23 expression, clinicopathologic prognostic factors and survival. (biomedsearch.com)
  • Mutations in BRCA1/BRCA2, which are associated with familial predisposition, are present in 10% of cases, while TCGA data demonstrates that P53 is mutated in 96% of high-grade serous ovarian carcinomas. (aacrjournals.org)
  • These cells have a non-functional P53 due to SV40 large T-antigen transfection, resulting in a genetic background similar to high-grade serous ovarian carcinomas and their precursors. (aacrjournals.org)
  • What is the inside of cyst wall serous cystadenoma? (healthtap.com)
  • The combination of a cyst wall that is thickened and the absence of microcysts had a sensitivity of 100% and specificity of 78% for the diagnosis of mucinous cystadenoma compared with macrocystic serous cystadenoma. (qxmd.com)
  • Although there is considerable overlap, helpful EUS characteristics that differentiate mucinous cystadenoma from macrocystic serous cystadenoma include a thick cyst wall and microcysts. (qxmd.com)
  • This case shows the successful removal of a 6198-g ovarian serous cystadenoma by use of minimally invasive techniques. (okstate.edu)
  • A macrocystic variant of serous cystadenoma recently has been described, rendering this important distinction more difficult. (qxmd.com)
  • In addition, serous cystic neoplasms slowly grow, and if they grow large enough they can press on adjacent organs and cause symptoms. (wikipedia.org)
  • Histology of the resected mass shows a Graafian follicle and an inner lining of ciliated columnar epithelium, consistent with a benign cystadenoma derived from ovarian tissue. (biomedcentral.com)
  • Serous borderline tumours may display aggressive behaviour, and occasionally present with peritoneal or nodal metastases. (radiopaedia.org)